Hospital de Galdakao

Running trials

• Recruiting

  DESTINY Breast Respond HER2-(Ultra)Low Europe

  NCT05945732· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source

• Active, not recruiting

  Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients

  NCT05193019· Fundación EPIC· Source

• Active, not recruiting

  Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice

  NCT04899141· Fundación EPIC· Source

• Recruiting

  ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO

  NCT03563417· Aarhus University Hospital Skejby· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease1 recruiting

Closed trials

• Completed

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· Phase 3· Boehringer Ingelheim· Source

• Completed

  Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease

  NCT03885713· Phase 4· Fundación de Investigación Biomédica - Hospital Universitario de La Princesa· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Crohn's disease38 works · 1 trial
• Ulcerative colitis24 works · 1 trial